Tag Archive | "Watson"

Top 50 Pharma (top pharmaceutical companies)

Tags: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , ,


The term 'top pharma' can relate to the top pharmaceutical companies or the top 10 or 50... Read the full story

Actavis Inc (formerly Watson Pharmaceuticals): Company Profile

Tags: , ,


Actavis, a top pharmaceutical company, is reviewed in terms of partnering, licensing and M&A interests and activity over recent years Read the full story

M&A: Watson acquires Uteron Pharma for upto $305 million

Tags: , ,


A M&A deal was agreed and signed by Watson Pharmaceuticals, a big pharma company, with  Uteron Pharma for $150 million in cash up front, and up to $155 million in potential future milestone payments. Read the full story

Watson becomes Actavis in a much talked M&A deal

Tags: , , ,


Watson Pharmaceuticals agreed to sell rights to 18 drugs to win approval from the U.S. Federal Trade Commission for its m&a of Actavis Inc Read the full story

Big pharma giants, Watson & Actavis pharma partners with Par Pharmaceuticals for generic products

Tags: , , ,


Par Pharmaceutical Companies has entered into pharma partners agreements with two well know big pharma companies, Watson Pharmaceuticals and Actavis Group, respectively,to purchase for cash five generic products that are currently marketed in the U.S. Read the full story

Watson prices debt financing offering of $1.2 billion

Tags: , ,


Watson Pharmaceuticals announced the pricing of a debt financing offering of $1.2 billion of 1.875% senior notes due 2017, $1.7 billion of 3.250% senior notes due 2022 and $1.0 billion of 4.625% senior notes due 2042, for a total offering of $3.9 billion in aggregate principal amount. Read the full story

Pharma partners pact bring Amgen, Synthon & Watson Pharmaceuticals together

Tags: , , , ,


Synthon has entered into a global pharma partners license agreement with Amgen and Watson Pharmaceuticals, for Synthon’s trastuzumab, being developed as a biosimilar to Herceptin, which is currently approved for treatment of breast cancer and gastric cancer.

Read the full story

Partnering Agreements with Watson

Tags: , , , , , , ,


This report provides all the information you require to better understand Watson and its partnering interests and activities over the past seven years. Read the full story

Watson acquires Actavis for $5.9 billion in a much talked M&A deal

Tags: , , ,


Watson Pharmaceuticals and Actavis Group jointly announced that Watson has entered into a definitive M&A agreement to acquire privately held Actavis for an upfront payment of EUR4.25 billion Read the full story

Big pharma Watson may announce $6 billion deal for Actavis

Tags: , , , ,


Big pharma Watson Pharmaceuticals Inc. (WPI) might announce a deal to buy Actavis for  around $6 billion on Wednesday, the Reuters news agency said Monday on its  website, citing unnamed sources familiar with the matter Read the full story